The study was published last week in the journal Anesthesia & Analgesia showing low dose aspirin cuts severe coronavirus risk.
Low-dose aspirin could help keep coronavirus patients off of ventilators, decrease their chances of requiring admission to the intensive care unit and lower the risk of in-hospital death, according to the findings of a new study.
Researchers with George Washington University in a study published last week in the journal Anesthesia & Analgesia found that the affordable and readily available drug likely prevents small blood clots, ultimately protecting COVID-19 patients’ lungs, they said.
For the study, the team looked at the medical records of more than 400 patients who were admitted to GW Hospital, the University of Maryland Medical Center, Wake Forest Baptist Medical Center, or Northeast Georgia Health System between March and July 2020. Some of the patients (about 24%) received aspirin within the first day of their admission to one of the hospitals or had taken it in the seven days before they were admitted. About 76% did not take aspirin in the study.
Ms. Jenn Landers | Patient Advocate Alliance LLC Edited by Dr. Justin Groode